Status:

COMPLETED

Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma

Lead Sponsor:

University of Utah

Conditions:

Melanoma (Skin)

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

This is an open label phase II pilot study assessing the metabolomic and inflammatory effects of oral aspirin (ASA) in human subjects at risk for melanoma.

Detailed Description

Primary Objectives I. Open label trial in 60 patients to assess the capacity of either of one daily dose (81, 325 mg) of sub-chronic ASA administration to increase the plasma and nevus ASA metabolite...

Eligibility Criteria

Inclusion

  • Must have at least 2 nevi (each \>5 mm diameter) not clinically suspicious for melanoma that can be biopsied.
  • Must be older than age 18.
  • Must be able to receive informed consent and sign an approved consent form that conforms to federal and institutional guidelines.

Exclusion

  • The patient is a minor, under age 18.
  • The patient cannot speak / understand English or Spanish.
  • The patient is pregnant or breastfeeding.
  • The patient is a prisoner, critically or mentally ill, or otherwise incapacitated or considered vulnerable.
  • The patient has history of allergic reaction to ASA.
  • The patient has history of severe asthma.
  • The patient has been taking ASA or any NSAID in the past 2 weeks.
  • The patient has been taking a blood thinner in the past 2 weeks.
  • The patient has history of bleeding disorder.
  • The patient has history of peptic ulcer disease.
  • The patient has had recent intense UV exposure in the past month.

Key Trial Info

Start Date :

September 27 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 27 2019

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT04062032

Start Date

September 27 2016

End Date

February 27 2019

Last Update

February 18 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Huntsman Cancer Institute/University of Utah

Salt Lake City, Utah, United States, 84112